Clover Health Investments, Corp.CLOVNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.16% | -33.96% | +33.27% | +34.07% | +50.05% |
| Gross Profit Growth | +15.62% | +50.84% | +33.18% | -7.68% | -9.89% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -235.79% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -246.92% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -242.79% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -308.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -308.00% | +0.00% |
| Weighted Average Shares Growth | +1.96% | +2.13% | +2.20% | +4.39% | +4.60% |
| Weighted Average Shares Diluted Growth | +1.96% | +2.13% | -12.41% | +2.77% | +4.60% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -162.82% | -87.92% | -75.79% |
| Free Cash Flow Growth | +0.00% | +0.00% | -164.64% | -89.09% | -76.99% |
| Receivables Growth | -77.95% | +7.60% | -21.89% | -7.41% | +41.33% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -38.38% | +1.76% | -13.11% | -14.72% | -14.30% |
| Book Value per Share Growth | +4.27% | +16.63% | +12.44% | +1.48% | -4.75% |
| Debt Growth | -26.09% | -100.00% | -100.00% | -100.00% | -100.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -11.22% | +4.63% | +5.69% | +9.88% | +7.71% |